Close Menu

Jeanne Whalen at the Wall Street Journal examines the restructuring of R&D at GlaxoSmithKline, and other big drug companies, over the past decade. GSK "has carved its research group into dozens of such small units" in an effort to "turn a sluggish, bureaucratic R&D staff into a constellation of specialized teams capable of discovering cutting-edge drugs — much in the way biotech companies do,"she writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.